Rapid Micro Biosystems logo

Rapid Micro BiosystemsNASDAQ: RPID

Profile

Sector:

Healthcare

Country:

United States

IPO:

15 July 2021

Next earnings report:

01 November 2024

Last dividends:

N/A

Next dividends:

N/A
$50.64 M
-94%vs. 3y high
35%vs. sector
-vs. 3y high
-vs. sector
-86%vs. 3y high
29%vs. sector
-94%vs. 3y high
38%vs. sector

Price

pre-market | 20 min ago
$1.18+$0.11(+10.27%)

Dividend

No data over the past 3 years
$6.62 M$6.55 M
$6.62 M-$12.58 M

Analysts recommendations

Institutional Ownership

RPID Latest News

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
zacks.com01 November 2024 Sentiment: -

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago.

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
globenewswire.com23 October 2024 Sentiment: POSITIVE

LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024.

Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
globenewswire.com17 July 2024 Sentiment: POSITIVE

LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024.

Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research03 May 2024 Sentiment: POSITIVE

Rapid Micro Biosystems, Inc. (RPID) reported a quarterly loss of $0.31 per share, slightly higher than the Zacks Consensus Estimate of $0.29 per share but an improvement from the loss of $0.32 per share in the same quarter last year.

Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
Seeking Alpha01 March 2024 Sentiment: POSITIVE

Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
GlobeNewsWire20 February 2024 Sentiment: NEGATIVE

LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.

Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewsWire03 January 2024 Sentiment: POSITIVE

LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
GlobeNewsWire07 November 2023 Sentiment: POSITIVE

LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY:

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research03 November 2023 Sentiment: POSITIVE

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.38 per share a year ago.

Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
GlobeNewsWire19 October 2023 Sentiment: POSITIVE

LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2023 financial results prior to the market open on Friday, November 3, 2023.

What type of business is Rapid Micro Biosystems?

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

What sector is Rapid Micro Biosystems in?

Rapid Micro Biosystems is in the Healthcare sector

What industry is Rapid Micro Biosystems in?

Rapid Micro Biosystems is in the Medical Devices industry

What country is Rapid Micro Biosystems from?

Rapid Micro Biosystems is headquartered in United States

When did Rapid Micro Biosystems go public?

Rapid Micro Biosystems initial public offering (IPO) was on 15 July 2021

What is Rapid Micro Biosystems website?

https://www.rapidmicrobio.com

Is Rapid Micro Biosystems in the S&P 500?

No, Rapid Micro Biosystems is not included in the S&P 500 index

Is Rapid Micro Biosystems in the NASDAQ 100?

No, Rapid Micro Biosystems is not included in the NASDAQ 100 index

Is Rapid Micro Biosystems in the Dow Jones?

No, Rapid Micro Biosystems is not included in the Dow Jones index

When was Rapid Micro Biosystems the previous earnings report?

No data

When does Rapid Micro Biosystems earnings report?

The next expected earnings date for Rapid Micro Biosystems is 01 November 2024